| __timestamp | Johnson & Johnson | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 21954000000 | 1802274 |
| Thursday, January 1, 2015 | 21203000000 | 2512761 |
| Friday, January 1, 2016 | 19945000000 | 2894488 |
| Sunday, January 1, 2017 | 21420000000 | 8096274 |
| Monday, January 1, 2018 | 22540000000 | 7985229 |
| Tuesday, January 1, 2019 | 22178000000 | 8994597 |
| Wednesday, January 1, 2020 | 22084000000 | 29772000 |
| Friday, January 1, 2021 | 20118000000 | 33907000 |
| Saturday, January 1, 2022 | 19046000000 | 26579000 |
| Sunday, January 1, 2023 | 20112000000 | 49868547 |
| Monday, January 1, 2024 | 21969000000 |
In pursuit of knowledge
In the world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Johnson & Johnson, a titan in the industry, has consistently reported SG&A expenses averaging around $21 billion annually from 2014 to 2023. However, a notable decline of approximately 9% was observed from 2017 to 2022, reflecting strategic cost management.
In contrast, Verona Pharma plc, a smaller player, has seen its SG&A expenses grow significantly, from under $2 million in 2014 to nearly $50 million in 2023. This represents a staggering increase of over 2,600%, highlighting its aggressive expansion and investment in growth.
This comparison underscores the diverse strategies employed by pharmaceutical companies in managing operational costs, with Johnson & Johnson focusing on efficiency and Verona Pharma on growth.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and AstraZeneca PLC
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Johnson & Johnson or Merus N.V.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Johnson & Johnson vs Bausch Health Companies Inc. Trends and Insights
Breaking Down SG&A Expenses: Johnson & Johnson vs Galapagos NV
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Verona Pharma plc and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights